Steffen Lang, Novartis president of operations
April 14, 2023 03:42 PM EDTUpdated 04:12 PM
Deals
Pharma
Manufacturing

No­var­tis inks deal to help man­u­fac­ture J&J and Leg­end's Carvyk­ti

Nicole DeFeudis

Editor

J&J and Leg­end have called on No­var­tis to help man­u­fac­ture Carvyk­ti, the sec­ond BC­MA CAR-T ap­proved by the FDA.

No­var­tis signed a

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times